Exclusion of Kaposi Sarcoma From Analysis of Cancer Burden
- PMID: 28662221
- PMCID: PMC12272739
- DOI: 10.1001/jamaoncol.2016.7092
Exclusion of Kaposi Sarcoma From Analysis of Cancer Burden
Conflict of interest statement
Comment in
-
Exclusion of Kaposi Sarcoma From Analysis of Cancer Burden-Reply.JAMA Oncol. 2017 Oct 1;3(10):1429-1430. doi: 10.1001/jamaoncol.2017.1747. JAMA Oncol. 2017. PMID: 28662223 No abstract available.
Comment on
-
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015: A Systematic Analysis for the Global Burden of Disease Study.JAMA Oncol. 2017 Apr 1;3(4):524-548. doi: 10.1001/jamaoncol.2016.5688. JAMA Oncol. 2017. PMID: 27918777 Free PMC article.
References
-
- Global Burden of Disease Cancer Collaboration. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematicanalysis for the Global Burden of Disease Study. JAMA Oncol. 2017;3(4):524–548. - PMC - PubMed
-
- Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108. - PubMed
-
- Plummer M, de Martel C, Vignat J, Ferlay J, Bray F, Franceschi S. Globalburden of cancers attributable to infections in 2012: a synthetic analysis. Lancet Glob Health. 2016;4(9):e609–e616. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical